介入性腫瘤學市場規模、佔有率和成長分析（按產品類型、手術類型、癌症類型、最終用戶和地區分類）－2026-2033年產業預測

全球介入性腫瘤學市場規模預計在 2024 年達到 23.1 億美元，從 2025 年的 24.7 億美元成長到 2033 年的 41.8 億美元，在預測期（2026-2033 年）內複合年成長率為 6.8%。

介入性腫瘤學是癌症治療領域一個快速發展的分支，它結合了微創手術和先進的影像技術，包括CT、超音波、MRI和X光。這些手術旨在精準靶向並清除癌細胞，同時最大限度地減少侵入性手術的需求。利用血管內導管、切片穿刺針和消融電極等專用器械，即使腫瘤位於體內遠處，也能有效標標靶化。介入性腫瘤學與傳統的腫瘤治療方法（包括放射治療、手術和內科腫瘤學）相結合，提供以緩解症狀和改善預後為重點的治療，從而提升患者的整體體驗。這種方法適用於多種癌症類型，包括肝癌、腎癌、肺癌和乳癌，凸顯了其在現代癌症治療管理中的核心地位。

全球介入性腫瘤市場按產品、癌症類型、手術方式、最終用戶和地區進行細分。依產品分類，可分為栓塞裝置、消融裝置和輔助裝置。依癌症類型分類，可分為肝癌、腎癌、乳癌、肺癌、骨癌、攝護腺癌和其他癌症。依手術方式分類，可分為經導管動脈放射乳化/選擇性體內放射療法（TARE/SIRT）、經導管動脈化療栓塞術（TACE）、熱消融術和經導管動脈栓塞/盲栓塞術（TAE）。依最終用戶分類，可分為醫院、門診手術中心以及科研和學術機構。按地區分類，可分為北美、歐洲、亞太、中東和非洲以及拉丁美洲。

全球介入性腫瘤學市場促進因素

全球癌症發生率的不斷攀升是介入腫瘤學市場的主要驅動力。隨著世界人口老化和生活方式相關風​​險因素導致癌症發生率上升，對有效治療方案的需求持續成長。這種日益成長的需求促使醫療專業人員採用先進的介入技術來改善患者預後並提高存活率。對創新治療方法的關注體現了應對癌症挑戰的決心，最終推動了介入腫瘤學領域的發展，並促進了患者照護和復原的進步。

全球介入腫瘤學市場面臨的限制因素

全球介入腫瘤學市場成長的主要限制因素是醫療專業人員對介入性腫瘤學技術的認知和訓練不足。許多醫療專業人員不熟悉最新的創新技術和流程，導致這些技術未能充分利用。此外，專業培訓的需求也會阻礙新技術在各種醫療機構中的快速應用，從而為將這些先進技術有效整合到日常患者照護中帶來挑戰。這種知識和訓練的匱乏最終會影響全球介入腫瘤學市場的整體發展和擴張。

全球介入性腫瘤學市場趨勢

全球介入腫瘤學市場正經歷著向微創技術的重大轉變，這主要源於患者和醫療服務提供者對能夠最大限度縮短恢復時間和減少併發症的治療方法日益成長的偏好。這一趨勢得益於技術的進步，促進了創新工具和調查方法的開發，從而提高了治療的精準度和療效。人們對這些方法的益處認知不斷提高，促使人們更加關注標靶治療不僅能改善患者預後，還能最佳化醫療資源配置。介入性腫瘤學的這一發展標誌著變革時期，其特徵是患者照護和滿意度的顯著提升。

目錄

介紹

• 調查目標
• 調查範圍
• 定義

調查方法

• 資訊收集
• 二手資料和一手資料方法
• 市場規模預測
• 市場假設與限制

執行摘要

• 全球市場展望
• 供需趨勢分析
• 細分市場機會分析

市場動態與展望

• 市場規模
• 市場動態
  • 促進因素和機遇
  • 限制與挑戰
• 波特分析

關鍵市場考察

• 關鍵成功因素
• 競爭程度
• 關鍵投資機會
• 市場生態系統
• 市場吸引力指數（2025）
• PESTEL 分析
• 總體經濟指標
• 價值鏈分析
• 定價分析
• 案例研究
• 監管環境

全球介入性腫瘤市場規模（按產品類型和複合年成長率分類）（2026-2033 年）

• 消融裝置
  • 射頻消融裝置
  • 微波消融裝置
  • 冷凍消融裝置
  • 不可逆電穿孔裝置
  • 高強度聚焦超音波（HIFU）系統
• 栓塞裝置
  • 放射性栓塞裝置（Y-90微球）
  • 經動脈化療栓塞術（TACE）藥物
  • 藥物釋放型球（DEBs）
  • 非藥物釋放型珠
• 支援的設備
  • 微導管
  • 導管導引線
  • 針頭（用於切片檢查和消融）
  • 導入器和鞘套
  • 造影
• 其他
  • 機器人輔助系統
  • 規劃和導航軟體平台

全球介入性腫瘤市場規模（依手術類型和複合年成長率分類）（2026-2033 年）

• 熱凝固療法
• 非熱消融
• 栓塞術
• 椎體成形術和骨水泥注射
• 切片檢查和腫瘤標記程序

全球介入性腫瘤學市場規模：癌症類型及複合年成長率（2026-2033）

• 肝癌
• 肺癌
• 腎癌
• 骨轉移
• 乳癌
• 攝護腺癌
• 胰臟癌
• 大腸直腸癌
• 其他

全球介入性腫瘤市場規模（依最終用戶分類）及複合年成長率（2026-2033 年）

• 醫院
• 門診手術中心（ASC）
• 癌症研究中心
• 介入放射科診所

全球介入性腫瘤市場規模及複合年成長率（2026-2033）

• 北美洲
  • 美國
  • 加拿大
• 歐洲
  • 德國
  • 西班牙
  • 法國
  • 英國
  • 義大利
  • 其他歐洲地區
• 亞太地區
  • 中國
  • 印度
  • 日本
  • 韓國
  • 亞太其他地區
• 拉丁美洲
  • 巴西
  • 其他拉丁美洲地區
• 中東和非洲
  • 海灣合作理事會國家
  • 南非
  • 其他中東和非洲地區

競爭資訊

• 前五大公司對比
• 主要企業的市場定位（2025 年）
• 主要市場參與者所採取的策略
• 近期市場趨勢
• 公司市佔率分析（2025 年）
• 主要企業公司簡介
  • 公司詳情
  • 產品系列分析
  • 依業務板塊進行公司股票分析
  • 2023-2025年營收年比比較

主要企業簡介

• Boston Scientific Corporation-USA
• Medtronic plc-Ireland
• Siemens Healthineers-Germany
• Terumo Corporation-Japan
• Becton, Dickinson and Company（BD）-USA
• Merit Medical Systems-USA
• AngioDynamics, Inc.-USA
• ALPINION MEDICAL SYSTEMS-South Korea
• ATRICURE, INC.-USA
• EndoShape, Inc.-USA
• ABK Biomedical Inc.-Canada
• Cook Medical Inc.-USA
• Sirtex Medical Limited-Australia
• BTG International Ltd.-UK
• Hologic, Inc.-USA
• Canon Medical Systems Corporation-Japan
• GE Healthcare-USA
• Philips Healthcare-Netherlands

結論與建議

Global Interventional Oncology Market size was valued at USD 2.31 Billion in 2024 and is poised to grow from USD 2.47 Billion in 2025 to USD 4.18 Billion by 2033, growing at a CAGR of 6.8% during the forecast period (2026-2033).

Interventional oncology represents a rapidly growing segment of cancer care that utilizes minimally invasive techniques combined with advanced imaging technologies such as CT, ultrasound, MRI, and X-rays. These procedures are designed to precisely target and eliminate cancer cells, minimizing the need for invasive surgeries. Utilizing specialized instruments like intravascular catheters, biopsy needles, and ablation electrodes ensures effective targeting of tumors, even those in remote areas of the body. The integration of interventional oncology with traditional oncology approaches-such as radiation therapy, surgery, and medical oncology-enhances the overall patient experience by providing focused treatments that relieve symptoms and improve outcomes. This approach is applicable to various cancers, including liver, kidney, lung, and breast cancers, emphasizing its pivotal role in contemporary cancer management.

Top-down and bottom-up approaches were used to estimate and validate the size of the Global Interventional Oncology market and to estimate the size of various other dependent submarkets. The research methodology used to estimate the market size includes the following details: The key players in the market were identified through secondary research, and their market shares in the respective regions were determined through primary and secondary research. This entire procedure includes the study of the annual and financial reports of the top market players and extensive interviews for key insights from industry leaders such as CEOs, VPs, directors, and marketing executives. All percentage shares split, and breakdowns were determined using secondary sources and verified through Primary sources. All possible parameters that affect the markets covered in this research study have been accounted for, viewed in extensive detail, verified through primary research, and analyzed to get the final quantitative and qualitative data.

Global Interventional Oncology Market Segments Analysis

Global Interventional Oncology Market is segmented on the basis of product, cancer type, procedure, end user, and region. By product, the market is segmented into Embolization Devices, Ablation Devices, and Support Devices. By Cancer Type, the market is segmented into Liver Cancer, Kidney Cancer, Breast Cancer, Lung Cancer, Bone Cancer, Prostate Cancer, and Other Cancers. By procedure, the market is segmented into Transcatheter Arterial Radioembolization/Selective Internal Radiation Therapy (TARE/SIRT), Transcatheter Arterial Chemoembolization (TACE), Thermal Tumor Ablation, and Transcatheter Arterial Embolization/Bland Embolization (TAE). By end-user, the market is segmented into hospitals, ambulatory surgery centers, and research & academic institutes. By region, the market is segmented into North America, Europe, Asia Pacific, Middle East and Africa, and Latin America.

Driver of the Global Interventional Oncology Market

The rising incidence of cancer worldwide significantly fuels the interventional oncology market. As the global population ages and lifestyle-related risk factors contribute to higher cancer rates, the need for effective treatment solutions continues to surge. This escalating demand encourages healthcare professionals to embrace advanced interventional techniques that improve patient outcomes and boost survival rates. The focus on innovative treatment methods reflects a commitment to addressing the challenges posed by cancer, ultimately driving the growth of the interventional oncology sector and fostering advancements in patient care and recovery.

Restraints in the Global Interventional Oncology Market

A significant constraint on the growth of the Global Interventional Oncology market is the limited awareness and training among healthcare professionals regarding interventional oncology techniques. Many practitioners lack familiarity with the latest innovations and procedures, which contributes to their underutilization. Furthermore, the necessity for specialized training can impede the swift adoption of new technologies across various healthcare environments, posing a challenge to effectively integrating these advanced practices into regular patient care. This lack of knowledge and training ultimately affects the overall development and expansion of interventional oncology within the global market.

Market Trends of the Global Interventional Oncology Market

The Global Interventional Oncology market is witnessing a pronounced shift towards minimally invasive techniques, reflecting a growing preference among patients and healthcare providers for treatments that minimize recovery times and complications. This trend is propelled by advancements in technology, fostering the development of innovative tools and methodologies that enhance precision and treatment efficacy. As awareness of the benefits of these approaches spreads, there is an increasing emphasis on targeted therapies that not only improve patient outcomes but also optimize healthcare resources. This evolution in interventional oncology signifies a transformative period characterized by enhanced patient care and satisfaction.

Table of Contents

Introduction

• Objectives of the Study
• Scope of the Report
• Definitions

Research Methodology

• Information Procurement
• Secondary & Primary Data Methods
• Market Size Estimation
• Market Assumptions & Limitations

Executive Summary

• Global Market Outlook
• Supply & Demand Trend Analysis
• Segmental Opportunity Analysis

Market Dynamics & Outlook

• Market Overview
• Market Size
• Market Dynamics
  • Drivers & Opportunities
  • Restraints & Challenges
• Porters Analysis
  • Competitive rivalry
  • Threat of substitute
  • Bargaining power of buyers
  • Threat of new entrants
  • Bargaining power of suppliers

Key Market Insights

• Key Success Factors
• Degree of Competition
• Top Investment Pockets
• Market Ecosystem
• Market Attractiveness Index, 2025
• PESTEL Analysis
• Macro-Economic Indicators
• Value Chain Analysis
• Pricing Analysis
• Case Studies
• Regulatory Landscape

Global Interventional Oncology Market Size by Product Type & CAGR (2026-2033)

• Market Overview
• Ablation Devices
  • Radiofrequency (RF) Ablation Devices
  • Microwave Ablation Devices
  • Cryoablation Devices
  • Irreversible Electroporation Devices
  • High-Intensity Focused Ultrasound (HIFU) Systems
• Embolization Devices
  • Radioembolization Devices (Y-90 Microspheres)
  • Transarterial Chemoembolization (TACE) Agents
  • Drug-Eluting Beads (DEBs)
  • Non-drug-eluting Beads
• Support Devices
  • Microcatheters
  • Guidewires
  • Needles (biopsy, ablation)
  • Introducers and Sheaths
  • Imaging Contrast Agents
• Others
  • Robotic Assistance Systems
  • Software Platforms for Planning and Navigation

Global Interventional Oncology Market Size by Procedure Type & CAGR (2026-2033)

• Market Overview
• Thermal Ablation
• Non-thermal Ablation
• Embolization Procedures
• Vertebroplasty & Cementoplasty
• Biopsy and Tumor Marking Procedures

Global Interventional Oncology Market Size by Cancer Type & CAGR (2026-2033)

• Market Overview
• Liver Cancer
• Lung Cancer
• Kidney Cancer
• Bone Metastases
• Breast Cancer
• Prostate Cancer
• Pancreatic Cancer
• Colorectal Cancer
• Others

Global Interventional Oncology Market Size by End User & CAGR (2026-2033)

• Market Overview
• Hospitals
• Ambulatory Surgical Centers (ASCs)
• Cancer Research Centers
• Interventional Radiology Clinics

Global Interventional Oncology Market Size & CAGR (2026-2033)

• North America (Product Type, Procedure Type, Cancer Type, End User)
  • US
  • Canada
• Europe (Product Type, Procedure Type, Cancer Type, End User)
  • Germany
  • Spain
  • France
  • UK
  • Italy
  • Rest of Europe
• Asia Pacific (Product Type, Procedure Type, Cancer Type, End User)
  • China
  • India
  • Japan
  • South Korea
  • Rest of Asia-Pacific
• Latin America (Product Type, Procedure Type, Cancer Type, End User)
  • Brazil
  • Rest of Latin America
• Middle East & Africa (Product Type, Procedure Type, Cancer Type, End User)
  • GCC Countries
  • South Africa
  • Rest of Middle East & Africa

Competitive Intelligence

• Top 5 Player Comparison
• Market Positioning of Key Players, 2025
• Strategies Adopted by Key Market Players
• Recent Developments in the Market
• Company Market Share Analysis, 2025
• Company Profiles of All Key Players
  • Company Details
  • Product Portfolio Analysis
  • Company's Segmental Share Analysis
  • Revenue Y-O-Y Comparison (2023-2025)

Key Company Profiles

• Boston Scientific Corporation - USA
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Medtronic plc - Ireland
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Siemens Healthineers - Germany
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Terumo Corporation - Japan
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Becton, Dickinson and Company (BD) - USA
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Merit Medical Systems - USA
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• AngioDynamics, Inc. - USA
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• ALPINION MEDICAL SYSTEMS - South Korea
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• ATRICURE, INC. - USA
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• EndoShape, Inc. - USA
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• ABK Biomedical Inc. - Canada
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Cook Medical Inc. - USA
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Sirtex Medical Limited - Australia
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• BTG International Ltd. - UK
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Hologic, Inc. - USA
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Canon Medical Systems Corporation - Japan
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• GE Healthcare - USA
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Philips Healthcare - Netherlands
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments

Conclusion & Recommendations